InvestorsHub Logo
Followers 80
Posts 24702
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 10/17/2017 8:36:18 AM

Tuesday, October 17, 2017 8:36:18 AM

Post# of 27621
CLRB - 1.71 Pre-market now at 1.80/1.85

Cellectar Biosciences Receives Additional Japanese Patent for CLR 131 and CLR 125 for the Treatment of Various Solid Tumors



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.